Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
Triveni Bio October 2024 Series B Funding Round

Triveni Bio October 2024 Series B Funding Round

Triveni Bio Raises $115 Million Series B Financing to Expand Pipeline of Therapeutics Addressing Immunological and Inflammatory (I&I) Disorders

OverviewStructured DataIssuesContributorsActivity

Currently, there are no issues on this topic.

Find more entities like Triveni Bio October 2024 Series B Funding Round

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo